Quarterly report [Sections 13 or 15(d)]

Stockholders' Equity - Stock Option Activity (Detail)

v3.25.1
Stockholders' Equity - Stock Option Activity (Detail) - USD ($)
3 Months Ended 12 Months Ended
Feb. 28, 2025
Nov. 30, 2024
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Granted 103,000  
Service-Based Vesting Condition Options [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Outstanding at November 30, 2024 493,878  
Granted 103,000  
Exercised 0  
Expired/forfeited (45,000)  
Outstanding at February 28, 2025 551,878 493,878
Exercisable at February 28, 2025 417,529  
Outstanding at November 30, 2024, Weighted Average Exercise Price $ 7.26  
Granted, Weighted Average Exercise Price 7.89  
Exercised, Weighted Average Exercise Price 0  
Expired/forfeited, Weighted Average Exercise Price 13.48  
Outstanding at February 28, 2025, Weighted Average Exercise Price 6.87 $ 7.26
Exercisable at February 28, 2025, Weighted Average Exercise Price $ 6.8  
Outstanding, Weighted Average Remaining Contractual Term (Years) 4 years 1 month 17 days 3 years 9 months 29 days
Exercisable at February 28, 2025, Weighted Average Remaining Contractual Term (Years) 4 years 7 days  
Outstanding at November 30, 2024, Aggregate Intrinsic Value $ 997,943  
Granted, Aggregate Intrinsic Value 15,400  
Exercised, Aggregate Intrinsic Value 0  
Expired/forfeited, Aggregate Intrinsic Value 0  
Outstanding at February 28, 2025, Aggregate Intrinsic Value 705,134 $ 997,943
Exercisable at February 28, 2025, Aggregate Intrinsic Value $ 574,974